• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染和脓毒症的生物标志物。

Biomarkers of Infection and Sepsis.

机构信息

Infectious Disease Division, Alpert Medical School of Brown University, Ocean State Clinical Coordinating Center at Rhode Island Hospital, 1 Virginia Avenue Suite 105, Providence, RI 02905, USA.

Critical Care Department, (Pr Laterre), Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, 1200 Brussels, Belgium.

出版信息

Crit Care Clin. 2020 Jan;36(1):11-22. doi: 10.1016/j.ccc.2019.08.002. Epub 2019 Oct 21.

DOI:10.1016/j.ccc.2019.08.002
PMID:31733673
Abstract

The role of biomarkers for detection of sepsis has come a long way. Molecular biomarkers are taking front stage at present, but machine learning and other computational measures using bigdata sets are promising. Clinical research in sepsis is hampered by lack of specificity of the diagnosis; sepsis is a syndrome with no uniformly agreed definition. This lack of diagnostic precision means there is no gold standard for this diagnosis. The final conclusion is expert opinion, which is not bad but not perfect. Perhaps machine learning will displace expert opinion as the final and most accurate definition for sepsis.

摘要

生物标志物在脓毒症检测中的作用已经有了很大的发展。目前,分子生物标志物占据主导地位,但利用大数据集的机器学习和其他计算方法也很有前途。脓毒症的临床研究受到诊断特异性缺乏的阻碍;脓毒症是一种综合征,没有普遍同意的定义。这种诊断精度的缺乏意味着没有这个诊断的金标准。最终的结论是专家意见,这并不差,但也不完美。也许机器学习将取代专家意见,成为脓毒症的最终和最准确的定义。

相似文献

1
Biomarkers of Infection and Sepsis.感染和脓毒症的生物标志物。
Crit Care Clin. 2020 Jan;36(1):11-22. doi: 10.1016/j.ccc.2019.08.002. Epub 2019 Oct 21.
2
The History of Biomarkers: How Far Have We Come?生物标志物的历史:我们走了多远?
Crit Care Clin. 2020 Jan;36(1):1-10. doi: 10.1016/j.ccc.2019.08.001. Epub 2019 Oct 21.
3
Molecular and biomarker-based diagnostics in early sepsis: current challenges and future perspectives.早期脓毒症的分子和生物标志物诊断:当前的挑战和未来的展望。
Expert Rev Mol Diagn. 2019 Dec;19(12):1069-1078. doi: 10.1080/14737159.2020.1680285. Epub 2019 Oct 15.
4
Procalcitonin as a diagnostic marker for sepsis/septic shock in the emergency department; a study based on Sepsis-3 definition.降钙素原作为急诊科脓毒症/脓毒性休克的诊断标志物:基于 Sepsis-3 定义的研究。
Am J Emerg Med. 2019 Feb;37(2):272-276. doi: 10.1016/j.ajem.2018.05.047. Epub 2018 May 26.
5
Machine Learning Algorithms Identify Pathogen-Specific Biomarkers of Clinical and Metabolomic Characteristics in Septic Patients with Bacterial Infections.机器学习算法可识别细菌性感染脓毒症患者的临床和代谢组学特征的病原体特异性生物标志物。
Biomed Res Int. 2020 Jul 27;2020:6950576. doi: 10.1155/2020/6950576. eCollection 2020.
6
Translational research and biomarkers in neonatal sepsis.新生儿败血症的转化研究与生物标志物
Clin Chim Acta. 2015 Dec 7;451(Pt A):46-64. doi: 10.1016/j.cca.2015.01.031. Epub 2015 Feb 4.
7
Novel biomarkers for sepsis: A narrative review.用于脓毒症的新型生物标志物:叙述性综述。
Eur J Intern Med. 2017 Nov;45:46-50. doi: 10.1016/j.ejim.2017.09.030. Epub 2017 Sep 29.
8
Early diagnosis of sepsis using serum biomarkers.使用血清生物标志物进行脓毒症的早期诊断。
Expert Rev Mol Diagn. 2011 Jun;11(5):487-96. doi: 10.1586/erm.11.26.
9
Diagnosing sepsis - The role of laboratory medicine.诊断脓毒症——检验医学的作用。
Clin Chim Acta. 2016 Sep 1;460:203-10. doi: 10.1016/j.cca.2016.07.002. Epub 2016 Jul 4.
10
The Use of Procalcitonin (PCT) for Diagnosis of Sepsis in Burn Patients: A Meta-Analysis.降钙素原(PCT)在烧伤患者脓毒症诊断中的应用:一项Meta分析
PLoS One. 2016 Dec 22;11(12):e0168475. doi: 10.1371/journal.pone.0168475. eCollection 2016.

引用本文的文献

1
Potential of biomarker-based enrichment strategies to identify critically ill patients for emerging cell death interventions.基于生物标志物的富集策略在识别适合新兴细胞死亡干预措施的危重症患者方面的潜力。
Cell Death Differ. 2025 Jul 19. doi: 10.1038/s41418-025-01545-0.
2
Likelihood of blood culture positivity using SeptiCyte RAPID.使用SeptiCyte RAPID进行血培养阳性的可能性。
medRxiv. 2025 May 13:2025.05.09.25327025. doi: 10.1101/2025.05.09.25327025.
3
S100P is a core gene for diagnosing and predicting the prognosis of sepsis.S100P是用于诊断和预测脓毒症预后的核心基因。
Sci Rep. 2025 Feb 25;15(1):6718. doi: 10.1038/s41598-025-90858-8.
4
Comparison between traditional logistic regression and machine learning for predicting mortality in adult sepsis patients.传统逻辑回归与机器学习在预测成年脓毒症患者死亡率方面的比较。
Front Med (Lausanne). 2025 Jan 6;11:1496869. doi: 10.3389/fmed.2024.1496869. eCollection 2024.
5
Rapid and Robust Identification of Sepsis Using SeptiCyte RAPID in a Heterogeneous Patient Population.在异质患者群体中使用SeptiCyte RAPID快速且可靠地识别脓毒症
J Clin Med. 2024 Oct 10;13(20):6044. doi: 10.3390/jcm13206044.
6
Immune cell composition and its impact on prognosis in children with sepsis.免疫细胞组成及其对脓毒症患儿预后的影响。
BMC Pediatr. 2024 Sep 28;24(1):611. doi: 10.1186/s12887-024-05087-1.
7
Lactylation: An Innovative Approach to Disease Control.乳酰化:疾病控制的创新方法。
Aging Dis. 2024 Sep 6. doi: 10.14336/AD.2024.0918.
8
Combining host immune response biomarkers and clinical scores for early prediction of sepsis in infection patients.将宿主免疫反应生物标志物与临床评分相结合,用于感染患者脓毒症的早期预测。
Ann Med. 2024 Dec;56(1):2396569. doi: 10.1080/07853890.2024.2396569. Epub 2024 Aug 30.
9
Exploring biomarkers for diagnosing and predicting organ dysfunction in patients with perioperative sepsis: a preliminary investigation.探索围手术期脓毒症患者器官功能障碍的诊断和预测生物标志物:一项初步调查。
Perioper Med (Lond). 2024 Jul 24;13(1):81. doi: 10.1186/s13741-024-00438-z.
10
Gut microbiota in preterm infants with late-onset sepsis and pneumonia: a pilot case-control study.早产儿晚发型败血症和肺炎的肠道菌群:一项初步病例对照研究。
BMC Microbiol. 2024 Jul 22;24(1):272. doi: 10.1186/s12866-024-03419-w.